ClinicalTrials.govpublic full text
Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplant
multiple myeloma, myeloma-associated amyloidosis, symptomatic multiple myeloma, myeloma post-ahct, myeloma post-transplant, multiple myeloma with amyloid deposition, post-transplant maintenance, minimal residual disease, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 912555
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.